Overview

Concentrations of Remifentanil for Extubation

Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
Condition of the State: (terminated, recruiting, etc.) Terminated Study Design: Main Objective: Compare the frequency and intensity of coughing at the time of extubation with two infusions of remifentanil that predict a plasma concentration (PC) of 3 - 4 and 2 - 3 ng/ml, through the technique of target controlled anesthesia
Phase:
Phase 4
Details
Lead Sponsor:
Seganest
Collaborator:
Instituto Para Ninos Ciegos y Sordos del Valle del Cauca
Treatments:
Remifentanil